PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > Formulary Search > PAD Profile : Terbutaline sulphate - Asthma
PAD Profile : Terbutaline sulphate - Asthma
Keywords :
Severe acute asthma, severe respiratory disease
Traffic Light Status
Status 1 of 2.
Status :
Red
Important
Formulations :
- Injection
Important Information :
Severe acute asthma
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Comments :
No comments returned.
Documents :
Status 2 of 2.
Status :
Blue
Important
Formulations :
- Nebules
Important Information :
Primary Care may prescribe on recommendation from the Respiratory Care Team who will ensure that patients have had suitable training and trial of equipment to ensure safe use.
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Comments :
No comments returned.
Documents :
Guidelines
No guidelines returned.
Other Drugs
- Fostair NEXThaler (beclometasone and formoterol)
- Montelukast
- Theophylline
- Easyhaler (Salbutamol)
- Clenil Modulite (beclometasone)
- Easyhaler (Beclometasone)
- Easyhaler (Budesonide)
- Fostair (Beclometasone and formoterol)
- Budelin Novolizer (budesonide)
- Dupilumab
- Airflusal (Salmeterol/Fluticasone) MDI
- Aerivio Spiromax (Fluticasone/Salmeterol) DPI
- Ventolin Accuhaler (salbutamol)
- Sereflo Ciphaler (Salmeterol / Fluticasone) DPI
- Campona Airmaster (Salmeterol / Fluticasone) DPI
- Salbutamol
- Budesonide
- Salamol Easi-Breathe
Other Indications
Additional Documents
No additional documents returned.
Committee Recommendations
Date
Committee Name
Narrative
06 November 2024
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)
Terbutaline nebules:
The Respiratory Care Team will ensure that the patient has undergone a suitable trial and training re use of equipment, response and safety. After this trial GPs may prescribe following a request from the respiratory care team. The advice will include frequency and duration of treatment, and whether additional support is required for the patients, e.g. wrap around frequent or long-term steroids.
Associated BNF Codes
03. Respiratory System
03.01.01. Adrenoceptor agonists